FDG PET/CT in the management of primary pleural tumors and pleural metastases

Matthew Kruse, Steven J. Sherry, Vasavi Paidpally, Gustavo Mercier, Rathan M. Subramaniam

Research output: Contribution to journalReview article

14 Scopus citations

Abstract

Objective. FDG PET/CT is emerging as an important modality in the evaluation of pleural tumors. PET/CT has an established role in the diagnosis and staging and shows promise in therapy planning, therapy response assessment, and providing prognostic information in patients with malignant pleural mesothelioma. This modality has distinct advantages in characterizing other primary pleural tumors and pleural metastases. Conclusion. FDG PET/CT is a useful imaging modality in the management of patients with primary pleural tumors and pleural metastases.

Original languageEnglish (US)
Pages (from-to)W215-W226
JournalAmerican Journal of Roentgenology
Volume201
Issue number2
DOIs
StatePublished - Aug 1 2013

Keywords

  • Metabolic tumor volume
  • PET/CT
  • Pleural metastases
  • Pleural tumors

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Fingerprint Dive into the research topics of 'FDG PET/CT in the management of primary pleural tumors and pleural metastases'. Together they form a unique fingerprint.

  • Cite this

    Kruse, M., Sherry, S. J., Paidpally, V., Mercier, G., & Subramaniam, R. M. (2013). FDG PET/CT in the management of primary pleural tumors and pleural metastases. American Journal of Roentgenology, 201(2), W215-W226. https://doi.org/10.2214/AJR.13.10572